9VZ8 image
Deposition Date 2025-07-22
Release Date 2026-02-11
Last Version Date 2026-07-01
Entry Detail
PDB ID:
9VZ8
Title:
Local refinement region of HPV45 in complex with antibody 10G2
Biological Source:
Source Organism(s):
Expression System(s):
Method Details:
Experimental Method:
Resolution:
3.81 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Major capsid protein L1
Gene (Uniprot):L1
Chain IDs:A (auth: C), B (auth: D), C (auth: E)
Chain Length:513
Number of Molecules:3
Biological Source:human papillomavirus 45
Structural Superimposition Protein Blast
Polymer Type:polypeptide(L)
Molecule:10G2 Fab heavy chain
Chain IDs:E (auth: H)
Chain Length:120
Number of Molecules:1
Biological Source:Mus musculus
Structural Superimposition Protein Blast
Polymer Type:polypeptide(L)
Molecule:10G2 Fab light chain
Chain IDs:D (auth: L)
Chain Length:111
Number of Molecules:1
Biological Source:Mus musculus
Ligand Molecules
Primary Citation
Structural and biochemical characterization of neutralizing antibodies targeting human papillomavirus type 45.
Structure 34 588 598.e4 (2026)
PMID: 41722563 DOI: 10.1016/j.str.2026.01.012

Abstact

Human papillomavirus type 45 (HPV45) is a high-risk genotype and the third most prevalent HPV type associated with cervical cancer worldwide, posing a significant public health concern. Although HPV45 is included in the commercial 9-valent HPV vaccine, its complete virion structure and the molecular basis of antibody-mediated neutralization remain incompletely understood. Here, we report the near-atomic resolution structure of the HPV45 pseudovirus (PsV45) determined by cryo-electron microscopy. We also isolated and structurally characterized several neutralizing monoclonal antibodies (nAbs) targeting PsV45. Our analysis reveals two distinct neutralizing epitopes on PsV45, and these nAbs likely neutralize the virus by a common mechanism involving the inhibition of viral attachment, despite differences in their binding interfaces. Biochemical assays confirmed that antibodies with non-overlapping binding modes can engage PsV45 simultaneously, indicating potential for synergistic combinations. These findings elucidate the structural basis of HPV45 type specificity and provide insights into HPV neutralization mechanisms.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback